1. Holmes D. Ovarian cancer: Beyond resistance. Nature 2015;527:S217.
2. Karst AM, Drapkin R. Ovarian cancer pathogenesis: A model in evolution. J Oncol 2010;2010:932371-932383.
3. Akter S, Rahman MA, Hasan MN, Akhter H, Noor P, Islam R, et al. Recent advances in ovarian cancer: Therapeutic strategies, potential biomarkers, and technological improvements. Cells 2022;11:650-670.
4. Chakraborti S, Ray BK, Roychoudhury S. Handbook of Oxidative Stress in Cancer: Mechanistic Aspects: Springer; 2020.
5. de Sá Junior PL, Câmara DAD, Porcacchia AS, Fonseca PMM, Jorge SD, Araldi RP, et al. The roles of ROS in cancer heterogeneity and therapy. Oxid Med Cell Longev 2017;2017:2467940-2467951.
6. Li X, Wang S, Mu W, Barry J, Han A, Carpenter RL, et al. Reactive oxygen species reprogram macrophages to suppress antitumor immune response through the exosomal miR-155-5p/PD-L1 pathway. J Exp Clin Cancer Res 2022;41:1-19.
7. Aggarwal V, Tuli HS, Varol A, Thakral F, Yerer MB, Sak K, et al. Role of reactive oxygen species in cancer progression: Molecular mechanisms and recent advancements. Biomolecules 2019;9:735-760.
8. Li H, Qiu Z, Li F, Wang C. The relationship between MMP-2 and MMP-9 expression levels with breast cancer incidence and prognosis. Oncol Lett 2017;14:5865-5870.
9. Quintero-Fabián S, Arreola R, Becerril-Villanueva E, Torres-Romero JC, Arana-Argáez V, Lara-Riegos J, et al. Role of matrix metalloproteinases in angiogenesis and cancer. Front Oncol 2019;9:1370-1390.
10. Steichen SD, Caldorera-Moore M, Peppas NA. A review of current nanoparticle and targeting moieties for the delivery of cancer therapeutics. Eur J Pharm Sci 2013;48:416-427.
11. Sawant RR, Jhaveri AM, Koshkaryev A, Zhu L, Qureshi F, Torchilin VP. Targeted transferrin-modified polymeric micelles: enhanced efficacy in vitro and in vivo in ovarian carcinoma. Mol Pharm 2014;11:375-381.
12. Wang X, Zhong X, Li J, Liu Z, Cheng L. Inorganic nanomaterials with rapid clearance for biomedical applications. Chem Soc Rev 2021;50:8669-8742.
13. Ning S, Dai X, Tang W, Guo Q, Lyu M, Zhu D, et al. Cancer cell membrane-coated C-TiO2 hollow nanoshells for combined sonodynamic and hypoxia-activated chemotherapy. Acta Biomater 2022;152:562-574.
14. Kalaiarasi A, Sankar R, Anusha C, Saravanan K, Aarthy K, Karthic S, et al. Copper oxide nanoparticles induce anticancer activity in A549 lung cancer cells by inhibition of histone deacetylase. Biotechnol Lett 2018;40:249-256.
15. Kafshdooz L, Kafshdooz T, Razban Z, Akbarzadeh A. The application of gold nanoparticles as a promising therapeutic approach in breast and ovarian cancer. Artif Cells Nanomed Biotechnol 2016;44:1222-1227.
16. Rank Miranda R, Pereira da Fonseca M, Korzeniowska B, Skytte L, Lund Rasmussen K, Kjeldsen F. Elucidating the cellular response of silver nanoparticles as a potential combinatorial agent for cisplatin chemotherapy. J Nanobiotechnology 2020;18:1-15.
17. Wang X, Li F, Yan X, Ma Y, Miao Z-H, Dong L, et al. Ambient aqueous synthesis of ultrasmall Ni0. 85Se nanoparticles for noninvasive photoacoustic imaging and combined photothermal-chemotherapy of cancer. ACS Appl Mater Interfaces 2017;9:41782-41793.
18. Ma Y, Wang X, Chen H, Miao Z, He G, Zhou J, et al. Polyacrylic acid functionalized Co0. 85Se nanoparticles: An ultrasmall pH-responsive nanocarrier for synergistic photothermal-chemo treatment of cancer. ACS Biomater Sci Eng 2018;4:547-557.
19. Phan V, Walters J, Brownlow B, Elbayoumi T. Enhanced cytotoxicity of optimized liposomal genistein via specific induction of apoptosis in breast, ovarian and prostate carcinomas. J Drug Target 2013;21:1001-1011.
20. Wang X, Ma Y, Chen H, Wu X, Qian H, Yang X, et al. Novel doxorubicin loaded PEGylated cuprous telluride nanocrystals for combined photothermal-chemo cancer treatment. Colloids Surf B Biointerfaces 2017;152:449-458.
21. Matthaiou E-I, Barar J, Sandaltzopoulos R, Li C, Coukos G, Omidi Y. Shikonin-loaded antibody-armed nanoparticles for targeted therapy of ovarian cancer. Int J Nanomedicine 2014;9:1855-1870.
22. Shaikh IM, Tan K-B, Chaudhury A, Liu Y, Tan B-J, Tan BM, et al. Liposome co-encapsulation of synergistic combination of irinotecan and doxorubicin for the treatment of intraperitoneally grown ovarian tumor xenograft. J Control Release 2013;172:852-861.
23. Guo X, Mei J, Jing Y, Wang S. Curcumin-loaded nanoparticles with low-intensity focused ultrasound-induced phase transformation as tumor-targeted and Ph-sensitive theranostic nanoplatform of ovarian cancer. Nanoscale Res Lett 2020;15:1-11.
24. Li TSC, Yawata T, Honke K. Efficient siRNA delivery and tumor accumulation mediated by ionically cross-linked folic acid-poly (ethylene glycol)–chitosan oligosaccharide lactate nanoparticles: For the potential targeted ovarian cancer gene therapy. Eur J Pharm Sci 2014;52:48-61.
25. Ganta S, Singh A, Rawal Y, Cacaccio J, Patel NR, Kulkarni P, et al. Formulation development of a novel targeted theranostic nanoemulsion of docetaxel to overcome multidrug resistance in ovarian cancer. Drug Deliv 2016;23:958-970.
26. Xu B, Li M, Yu Y, He J, Hu S, Pan M, et al. Effects of harmaline on cell growth of human liver cancer through the p53/p21 and Fas/FasL signaling pathways. Oncol Lett 2018;15:1931-1936.
27. Abass Sofi M, Sunitha S, Ashaq Sofi M, Khadheer Pasha SK, Choi D. An overview of antimicrobial and anticancer potential of silver nanoparticles. J King Saud Univ Sci 2022;34:101791.
28. Saratale RG, Benelli G, Kumar G, Kim DS, Saratale GD. Bio-fabrication of silver nanoparticles using the leaf extract of an ancient herbal medicine, dandelion (Taraxacum officinale), evaluation of their antioxidant, anticancer potential, and antimicrobial activity against phytopathogens. Environ Sci Pollut Res 2018;25:10392-10406.
29. Kuppusamy P, Ichwan SJ, Al-Zikri PNH, Suriyah WH, Soundharrajan I, Govindan N, et al. In vitro anticancer activity of Au, Ag nanoparticles synthesized using Commelina nudiflora L. aqueous extract against HCT-116 colon cancer cells. Biol Trace Elem Res 2016;173:297-305.
30. Stetefeld J, McKenna SA, Patel TR. Dynamic light scattering: A practical guide and applications in biomedical sciences. Biophys Rev 2016;8:409-427.
31. Salopek B, Krasic D, Filipovic S. Measurement and application of zeta-potential. Rudarsko-geolosko-naftni zbornik 1992;4:147-151.
32. Chowdhury S, Basu A, Kundu S. Green synthesis of protein capped silver nanoparticles from phytopathogenic fungus Macrophomina phaseolina (Tassi) Goid with antimicrobial properties against multidrug-resistant bacteria. Nanoscale Res Lett 2014;9:365-375.
33. Mahmood S, Kiong KC, Tham CS, Chien TC, Hilles AR, Venugopal JR. PEGylated lipid polymeric nanoparticle-encapsulated acyclovir for in vitro controlled release and ex vivo gut sac permeation. AAPS PharmSciTech. 2020;21:1-15.
34. Azizi M, Sedaghat S, Tahvildari K, Derakhshi P, Ghaemi A. Synthesis of silver nanoparticles using Peganum harmala extract as a green route. Green Chem Lett Rev 2017;10:420-427.
35. Nakamura H, Takada K. Reactive oxygen species in cancer: Current findings and future directions. Cancer Sci 2021;112:3945-3952.
36. Fahrenholtz CD, Swanner J, Ramirez-Perez M, Singh RN. Heterogeneous responses of ovarian cancer cells to silver nanoparticles as a single agent and in combination with cisplatin. J Nanomater 2017;2017:5107485-5107504.
37. Piktel E, Ościłowska I, Suprewicz Ł, Depciuch J, Marcińczyk N, Chabielska E, et al. ROS-mediated apoptosis and autophagy in ovarian cancer cells treated with peanut-shaped gold nanoparticles. Int J Nanomedicine 2021;16:1993-2011.
38. Amalraj A, Pius A, Gopi S, Gopi S. Biological activities of curcuminoids, other biomolecules from turmeric and their derivatives: A review. J Tradit Complement Med 2017;7:205-233.
39. Majumder R, Das CK, Mandal M. Lead bioactive compounds of Aloe vera as potential anticancer agent. Pharmacol Res 2019;148:104416.
40. Zhang Y, Shi X, Xie X, Laster KV, Pang M, Liu K, et al. Harmaline isolated from Peganum harmala suppresses growth of esophageal squamous cell carcinoma through targeting mTOR. Phytother Res Phytother Res 2021;35:6377-6388.
41. Roy S, Mohammad T, Gupta P, Dahiya R, Parveen S, Luqman S, et al. Discovery of harmaline as a potent inhibitor of sphingosine kinase-1: A chemopreventive role in lung cancer. ACS Omega 2020;5:21550-21560.
42. Ogretmen B, Hannun YA. Biologically active sphingolipids in cancer pathogenesis and treatment. Nat Rev Cancer 2004;4:604-616.
43. Farran B, Montenegro RC, Kasa P, Pavitra E, Huh YS, Han YK, et al. Folate-conjugated nanovehicles: Strategies for cancer therapy. Mater Sci Eng C Mater Biol Appl 2020;107:110341.
44. He G, Ma Y, Zhou H, Sun S, Wang X, Qian H, et al. Mesoporous NiS 2 nanospheres as a hydrophobic anticancer drug delivery vehicle for synergistic photothermal-chemotherapy. J Mater Chem B 2019;7:143-149.
45. Andhariya N, Upadhyay R, Mehta R, Chudasama B. Folic acid conjugated magnetic drug delivery system for controlled release of doxorubicin. J Nanopart Res 2013;15:1-12.
46. Qu W, Meng B, Yu Y, Wang S. Folic acid-conjugated mesoporous silica nanoparticles for enhanced therapeutic efficacy of topotecan in retina cancers. Int J Nanomedicine 2018;13:4379-4389.
47. Liu Y, Li K, Pan J, Liu B, Feng SS. Folic acid conjugated nanoparticles of mixed lipid monolayer shell and biodegradable polymer core for targeted delivery of Docetaxel. Biomaterials 2010;31:330-338.
48. Carron PM, Crowley A, O’Shea D, McCann M, Howe O, Hunt M, et al. Targeting the folate receptor: Improving efficacy in inorganic medicinal chemistry. Curr Med Chem 2018;25:2675-2708.
49. Seyedi SMR, Asoodeh A, Darroudi M. The human immune cell simulated anti-breast cancer nanorobot: The efficient, traceable, and dirigible anticancer bio-bot. Cancer Nanotechnol 2022;13:1-24.
50. Wang Y, Wang C, Jiang C, Zeng H, He X. Novel mechanism of harmaline on inducing G2/M cell cycle arrest and apoptosis by up-regulating Fas/FasL in SGC-7901 cells. Sci Rep2015;5:18613-18622.
51. Lee YS, Kim DW, Lee YH, Oh JH, Yoon S, Choi MS, et al. Silver nanoparticles induce apoptosis and G2/M arrest via PKCζ-dependent signaling in A549 lung cells. Arch Toxicol 2011;85:1529-1540.
)